The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.

Kassim AA, DeBaun MR
Expert Opin Pharmacother. 2014 15 (3): 325-36

PMID: 24392871 · DOI:10.1517/14656566.2014.868435

MeSH Terms (11)

Anemia, Sickle Cell Antisickling Agents Blood Transfusion Chest Pain Child Hematopoietic Stem Cell Transplantation Humans Hydroxyurea Models, Statistical Pain Stroke

Connections (2)

This publication is referenced by other Labnodes entities: